Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study [Corrigendum]
2015 ◽
pp. 1513
2005 ◽
Vol 58
(5)
◽
pp. 498
◽
2012 ◽
Vol 28
(2)
◽
pp. 257-265
◽
2016 ◽
Vol 13
(6)
◽
pp. 686-692
◽
2013 ◽
Vol 1
(1)
◽
pp. 51-60
◽
2006 ◽
Vol 130
(4)
◽
pp. 182S
◽
2008 ◽